Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy
AbstractBurkholderia cepacia complex (Bcc) is a bacterial group with ‘natural’ multi-antimicrobial resistance. This complex has generated epidemic outbreaks across the world. In people with cystic fibrosis (CF), Bcc can cause severe lung infections that lead to accelerated lung damage, which can be...
Main Authors: | Juan Carlos Gutiérrez Santana, Victor Rafael Coria Jiménez |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2024.2307503 |
Similar Items
-
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
by: Bryan A. Garcia, et al.
Published: (2018-02-01) -
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01) -
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
by: David P. Speert, et al.
Published: (2002-02-01) -
Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients
by: Ergunay Koray, et al.
Published: (2008-06-01) -
Isolation And Identification Of Burkholderia Cepacia From Respiratory Secretions In Cyctic Fibrosis Patients
by: Celin Telefian, et al.
Published: (2015-09-01)